1.
Lattuada E, Lanzafame M, Grosso C, Soldani, et al. F. Optimal fosamprenavir regimen to prevent lipid abnormalities. Acta Biomed. 2009;80(3):200-202. Accessed February 7, 2025. https://mattioli1885journals.com/index.php/actabiomedica/article/view/1171